Stonebridge Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-176
Closed -$23.1K – 332
2023
Q3
$23.1K Buy
176
+27
+18% +$4.1K ﹤0.01% 475
2023
Q2
$23.7K Sell
149
-13
-8% -$2.1K ﹤0.01% 484
2023
Q1
$25.6K Sell
162
-25
-13% -$3.75K ﹤0.01% 467
2022
Q4
$26.2K Buy
187
+39
+26% +$5.54K ﹤0.01% 448
2022
Q3
$19K Sell
148
-18
-11% -$2.6K ﹤0.01% 476
2022
Q2
$23K Buy
166
+32
+24% +$4.57K ﹤0.01% 469
2022
Q1
$19K Hold
134
– – ﹤0.01% 537
2021
Q4
$23K Hold
134
– – ﹤0.01% 483
2021
Q3
$22K Sell
134
-7
-5% -$1.21K ﹤0.01% 472
2021
Q2
$25K Hold
141
– – ﹤0.01% 459
2021
Q1
$27K Buy
+141
New +$27.1K ﹤0.01% 446
2020
Q3
– Sell
-50
Closed -$11K – 278
2020
Q2
$11K Sell
50
-25
-33% -$5K ﹤0.01% 479
2020
Q1
$13K Hold
75
– – ﹤0.01% 449
2019
Q4
$12K Sell
75
-50
-40% -$7.47K ﹤0.01% 525
2019
Q3
$19K Hold
125
– – ﹤0.01% 451
2019
Q2
$19K Buy
+125
New +$19.1K ﹤0.01% 461

Other funds holding CLX

Stonebridge Capital Advisors's CLX Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Clorox (CLX) in Q4 2023, closing a stake of 176 shares — an estimated $23.1K sold.

Stonebridge Capital Advisors first reported a position in CLX in Q2 2019 and held it in 16 quarters. The position peaked at $27K in Q1 2021. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Clorox position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 176 Clorox shares in Q4 2023, an estimated $23.1K.
  • Stonebridge Capital Advisors first reported a position in Clorox in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Clorox position peaked at $27K in Q1 2021.
  • 1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.